Annual Operating Profit
-$46.35 M
+$109.34 M+70.23%
31 December 2021
Summary:
Aerie Pharmaceuticals annual operaing income is currently -$46.35 million, with the most recent change of +$109.34 million (+70.23%) on 31 December 2021. During the last 3 years, it has risen by +$109.34 million (+70.23%).AERI Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$26.67 M
-$8.54 M-47.06%
30 September 2022
Summary:
Aerie Pharmaceuticals quarterly operating income is currently -$26.67 million, with the most recent change of -$8.54 million (-47.06%) on 30 September 2022.AERI Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$26.71 M
+$5.70 M+17.59%
30 September 2022
Summary:
Aerie Pharmaceuticals TTM operating income is currently -$26.71 million, with the most recent change of +$5.70 million (+17.59%) on 30 September 2022.AERI TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +70.2% | +17.6% | +80.0% |
| 5 y5 years | +77.9% | +38.4% | +85.9% |
AERI Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +226.1% | -151.6% | +857.8% |
Aerie Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$26.67 M(+47.1%) | -$26.71 M(-17.6%) |
| June 2022 | - | -$18.14 M(-46.1%) | -$32.41 M(-29.2%) |
| Mar 2022 | - | -$33.64 M(-165.0%) | -$45.78 M(-1.2%) |
| Dec 2021 | -$46.35 M(-70.2%) | $51.74 M(-259.8%) | -$46.35 M(-65.3%) |
| Sept 2021 | - | -$32.37 M(+2.8%) | -$133.69 M(-0.9%) |
| June 2021 | - | -$31.50 M(-7.9%) | -$134.92 M(-7.6%) |
| Mar 2021 | - | -$34.22 M(-3.9%) | -$145.97 M(-6.2%) |
| Dec 2020 | -$155.69 M(-17.0%) | -$35.59 M(+5.9%) | -$155.69 M(-8.4%) |
| Sept 2020 | - | -$33.60 M(-21.0%) | -$170.03 M(-5.4%) |
| June 2020 | - | -$42.55 M(-3.2%) | -$179.76 M(-1.9%) |
| Mar 2020 | - | -$43.94 M(-12.0%) | -$183.28 M(-2.2%) |
| Dec 2019 | -$187.49 M(-10.6%) | -$49.94 M(+15.3%) | -$187.49 M(-1.0%) |
| Sept 2019 | - | -$43.33 M(-6.0%) | -$189.48 M(-8.7%) |
| June 2019 | - | -$46.08 M(-4.3%) | -$207.49 M(-4.4%) |
| Mar 2019 | - | -$48.15 M(-7.3%) | -$217.10 M(+3.5%) |
| Dec 2018 | -$209.74 M(+44.0%) | -$51.92 M(-15.3%) | -$209.74 M(-3.8%) |
| Sept 2018 | - | -$61.34 M(+10.2%) | -$218.13 M(+15.4%) |
| June 2018 | - | -$55.68 M(+36.5%) | -$188.97 M(+17.3%) |
| Mar 2018 | - | -$40.80 M(-32.4%) | -$161.06 M(+10.5%) |
| Dec 2017 | -$145.69 M | -$60.31 M(+87.4%) | -$145.69 M(+27.6%) |
| Sept 2017 | - | -$32.18 M(+15.9%) | -$114.14 M(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$27.77 M(+9.2%) | -$105.27 M(+5.1%) |
| Mar 2017 | - | -$25.43 M(-11.6%) | -$100.19 M(+3.4%) |
| Dec 2016 | -$96.87 M(+29.0%) | -$28.76 M(+23.3%) | -$96.87 M(+10.0%) |
| Sept 2016 | - | -$23.32 M(+2.8%) | -$88.06 M(+7.2%) |
| June 2016 | - | -$22.69 M(+2.6%) | -$82.12 M(+5.9%) |
| Mar 2016 | - | -$22.11 M(+10.8%) | -$77.56 M(+3.3%) |
| Dec 2015 | -$75.09 M(+50.3%) | -$19.95 M(+14.9%) | -$75.09 M(+5.6%) |
| Sept 2015 | - | -$17.37 M(-4.2%) | -$71.11 M(+6.3%) |
| June 2015 | - | -$18.13 M(-7.7%) | -$66.92 M(+10.4%) |
| Mar 2015 | - | -$19.64 M(+23.0%) | -$60.63 M(+21.3%) |
| Dec 2014 | -$49.97 M(+125.4%) | -$15.97 M(+21.2%) | -$49.97 M(+22.6%) |
| Sept 2014 | - | -$13.17 M(+11.2%) | -$40.75 M(+22.5%) |
| June 2014 | - | -$11.84 M(+31.9%) | -$33.26 M(+25.4%) |
| Mar 2014 | - | -$8.98 M(+33.1%) | -$26.53 M(+19.7%) |
| Dec 2013 | -$22.17 M(+55.1%) | -$6.75 M(+18.7%) | -$22.17 M(+18.5%) |
| Sept 2013 | - | -$5.69 M(+11.2%) | -$18.71 M(+18.3%) |
| June 2013 | - | -$5.11 M(+10.6%) | -$15.81 M(+47.8%) |
| Mar 2013 | - | -$4.62 M(+40.6%) | -$10.70 M(+76.1%) |
| Dec 2012 | -$14.29 M(+0.5%) | -$3.29 M(+17.9%) | -$6.08 M(+117.9%) |
| Sept 2012 | - | -$2.79 M | -$2.79 M |
| Dec 2011 | -$14.22 M | - | - |
FAQ
- What is Aerie Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Aerie Pharmaceuticals?
What is Aerie Pharmaceuticals annual operaing income?
The current annual operating profit of AERI is -$46.35 M
What is the all time high annual operating profit for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual operaing income is -$14.22 M
What is Aerie Pharmaceuticals quarterly operating income?
The current quarterly operating profit of AERI is -$26.67 M
What is the all time high quarterly operating profit for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly operating income is $51.74 M
What is Aerie Pharmaceuticals TTM operating income?
The current TTM operating profit of AERI is -$26.71 M
What is the all time high TTM operating profit for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high TTM operating income is -$2.79 M